AI Regulations News Today: EU AI Act Delay Wrangle Leaves Pharma in High‑Risk Limbo
27 months. That’s how quickly a European AI roadmap can slip if you misread the EU AI Act—and the coming delay could cost you even more
May 4, 2026
27 months. That’s how quickly a European AI roadmap can slip if you misread the EU AI Act—and the coming delay could cost you even more
With implementation due on 28 April 2026, the MHRA’s ICH GCP E6(R3) rollout is turning GCP compliance into an immediate operational issue for UK sponsors
AI in pharma just crossed a quiet line.
Not in production. Not in pilots.
But inside regulatory sandboxes designed to test what should be allowed next.